Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark G Swain

Showing results (31-40 of 135) with videos related to

Pageof 14
Sort By:
Plos One|May 21, 2021
Modelling the cost effectiveness of non-alcoholic fatty liver disease risk stratification strategies in the community settingStephen E Congly, Abdel Aziz Shaheen, Mark G Swain
Canadian Liver Journal|August 22, 2022
A Canadian survey on knowledge of non-alcoholic fatty liver disease among physiciansGiada Sebastiani, Alnoor Ramji, Mark G Swain, et al.
The American Journal of Pathology|September 18, 2010
Protective role of interleukin-17 in murine NKT cell-driven acute experimental hepatitisZenebech Wondimu, Tania Santodomingo-Garzon, Tai Le, et al.
ACG Case Reports Journal|January 10, 2025
Prominent Eustachian Valve Mimicking a Transjugular Intrahepatic Portosystemic Shunt-Associated ThrombosisGetanshu Malik, Eric Herget, Henry H Nguyen, et al.
Canadian Liver Journal|May 14, 2026
Chronic ketamine use resulting in a reversible cholangiopathy: A case series from a single Canadian centre and review of the literatureBryce Tkachuk, Liam Swain, Kelly W Burak, et al.
BMC Gastroenterology|June 27, 2018
A case series evaluating the impact of Hepatitis C eradication using direct acting antivirals on primary biliary cholangitis-associated autoimmunityHenry H Nguyen, Abdullah Khathlan, Marvin J Fritzler, et al.
Journal of Hepatology|April 26, 2003
Reversible sclerosing cholangitis secondary to cryptosporidiosis in a renal transplant patientAyman Abdo, John Klassen, Stefan Urbanski, et al.
Frontiers in Immunology|April 30, 2019
The Antidepressant Mirtazapine Inhibits Hepatic Innate Immune Networks to Attenuate Immune-Mediated Liver Injury in MiceWagdi Almishri, Abdel Aziz Shaheen, Keith A Sharkey, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 8, 2003
C-C chemokine ligand 2/monocyte chemoattractant protein-1 directly inhibits NKT cell IL-4 production and is hepatoprotective in T cell-mediated hepatitis in the mouseMaureen N Ajuebor, Cory M Hogaboam, Tai Le, et al.
CMAJ Open|December 5, 2018
Canadian regulations and legal ramifications for hepatic encephalopathy: a descriptive analysisHenry H Nguyen, Mark G Swain, Philip Wong, et al.
Pageof 14

Showing results (31-40 of 135) with videos related to

Sort By:
Pageof 14
Plos One|May 21, 2021
Modelling the cost effectiveness of non-alcoholic fatty liver disease risk stratification strategies in the community settingStephen E Congly, Abdel Aziz Shaheen, Mark G Swain
Canadian Liver Journal|August 22, 2022
A Canadian survey on knowledge of non-alcoholic fatty liver disease among physiciansGiada Sebastiani, Alnoor Ramji, Mark G Swain, et al.
The American Journal of Pathology|September 18, 2010
Protective role of interleukin-17 in murine NKT cell-driven acute experimental hepatitisZenebech Wondimu, Tania Santodomingo-Garzon, Tai Le, et al.
ACG Case Reports Journal|January 10, 2025
Prominent Eustachian Valve Mimicking a Transjugular Intrahepatic Portosystemic Shunt-Associated ThrombosisGetanshu Malik, Eric Herget, Henry H Nguyen, et al.
Canadian Liver Journal|May 14, 2026
Chronic ketamine use resulting in a reversible cholangiopathy: A case series from a single Canadian centre and review of the literatureBryce Tkachuk, Liam Swain, Kelly W Burak, et al.
BMC Gastroenterology|June 27, 2018
A case series evaluating the impact of Hepatitis C eradication using direct acting antivirals on primary biliary cholangitis-associated autoimmunityHenry H Nguyen, Abdullah Khathlan, Marvin J Fritzler, et al.
Journal of Hepatology|April 26, 2003
Reversible sclerosing cholangitis secondary to cryptosporidiosis in a renal transplant patientAyman Abdo, John Klassen, Stefan Urbanski, et al.
Frontiers in Immunology|April 30, 2019
The Antidepressant Mirtazapine Inhibits Hepatic Innate Immune Networks to Attenuate Immune-Mediated Liver Injury in MiceWagdi Almishri, Abdel Aziz Shaheen, Keith A Sharkey, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 8, 2003
C-C chemokine ligand 2/monocyte chemoattractant protein-1 directly inhibits NKT cell IL-4 production and is hepatoprotective in T cell-mediated hepatitis in the mouseMaureen N Ajuebor, Cory M Hogaboam, Tai Le, et al.
CMAJ Open|December 5, 2018
Canadian regulations and legal ramifications for hepatic encephalopathy: a descriptive analysisHenry H Nguyen, Mark G Swain, Philip Wong, et al.
Pageof 14